Company logo

SEER - Seer, Inc.

NASDAQ -> Healthcare -> Biotechnology
Redwood City, United States
Type: Equity

SEER price evolution
SEER
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $33.02 $36.92 $56.93 $48.91
Short term investments $283.73 $294.85 $263.81 $303.71
Net receivables $6.72 $7.75 $6.3 $7.18
Inventory $4.49 $4.22 $5.26 $3.72
Total current assets $330.51 $346.12 $335.38 $367.38
Long term investments $56.86 $49.57 $75.81 $58.42
Property, plant & equipment $47.37 $47.5 $48.49 $45.62
Goodwill & intangible assets
Total noncurrent assets $105.76 $98.73 $125.81 $105.41
Total investments $340.58 $344.43 $339.61 $362.12
Total assets $436.27 $444.85 $461.19 $472.79
Current liabilities
Accounts payable $1.37 $0.75 $5.25 $1.96
Deferred revenue $0.21 $0.18 $0.26 $0.26
Short long term debt $2.29 $2.31 $2.25 $2.19
Total current liabilities $13.22 $12.52 $15.8 $11.75
Long term debt $25.96 $26.5 $27.1 $27.68
Total noncurrent liabilities $26.14 $26.66 $27.27 $28.04
Total debt $28.26 $28.81 $29.34 $29.87
Total liabilities $39.37 $39.17 $43.08 $39.8
Shareholders' equity
Retained earnings -$305.77 -$287.97 -$266.89 -$243.46
Other shareholder equity -$0.19 -$1.3 -$1.53 -$0.09
Total shareholder equity $396.9 $405.68 $418.12 $432.99
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $33.02 $53.73 $233.34 $333.93
Short term investments $283.73 $368.03 $167.26 $98.28
Net receivables $6.72 $7.02 $4.14 $0.26
Inventory $4.49 $4.63 $4.14 $0.55
Total current assets $330.51 $434.98 $411.7 $433.13
Long term investments $56.86 $5.16 $93.19
Property, plant & equipment $47.37 $46.41 $33.23 $8.44
Goodwill & intangible assets
Total noncurrent assets $105.76 $52.95 $127.44 $9.19
Total investments $340.58 $373.19 $260.45 $98.28
Total assets $436.27 $487.93 $539.14 $442.32
Current liabilities
Accounts payable $1.37 $2.1 $3.79 $2.12
Deferred revenue $0.21 $0.13 $0.38 $0.25
Short long term debt $2.29 $1.84 $0.86
Total current liabilities $13.22 $12.58 $13.42 $8.09
Long term debt $25.96 $28.03 $22.46
Total noncurrent liabilities $26.14 $28.35 $22.8 $2.62
Total debt $28.26 $29.87 $23.32
Total liabilities $39.37 $40.94 $36.22 $10.71
Shareholders' equity
Retained earnings -$305.77 -$219.5 -$126.53 -$55.36
Other shareholder equity -$0.19 -$1.25 -$0.54 $0.05
Total shareholder equity $396.9 $446.99 $502.92 $431.61
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $4.44 $4.16 $4.01 $4.05
Cost of revenue $2.44 $2.01 $1.73 $1.99
Gross Profit $2 $2.16 $2.28 $2.07
Operating activities
Research & development $11.16 $13.23 $14.15 $14.47
Selling, general & administrative $13.07 $14.77 $16.07 $15.04
Total operating expenses $24.23 $28 $30.22 $29.51
Operating income -$22.23 -$25.84 -$27.94 -$27.45
Income from continuing operations
EBIT -$17.8 -$21.09 -$23.43 -$23.96
Income tax expense
Interest expense
Net income
Net income -$17.8 -$21.09 -$23.43 -$23.96
Income (for common shares) -$17.8 -$21.09 -$23.43 -$23.96
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $16.66 $15.49 $6.62 $0.66
Cost of revenue $8.15 $8.4 $3.21
Gross Profit $8.51 $7.09 $3.41 $0.66
Operating activities
Research & development $53.02 $45.8 $29.12 $18.94
Selling, general & administrative $58.95 $58.53 $45.76 $15.36
Total operating expenses $111.97 $104.33 $74.89 $34.3
Operating income -$103.46 -$97.23 -$71.47 -$33.65
Income from continuing operations
EBIT -$86.28 -$92.97 -$71.15 -$32.77
Income tax expense
Interest expense $0.02
Net income
Net income -$86.28 -$92.97 -$71.17 -$32.77
Income (for common shares) -$86.28 -$92.97 -$71.17 -$32.77
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$17.8 -$21.09 -$23.43 -$23.96
Operating activities
Depreciation $1.63 $1.5 $1.36 $1.31
Business acquisitions & disposals
Stock-based compensation $7.61 $8.33 $9.75 $8.72
Total cash flows from operations -$10.19 -$14.41 -$15.13 -$19.33
Investing activities
Capital expenditures -$1.84 -$4.2 -$1.15 -$0.12
Investments $7.95 -$1.42 $24.09 $14.6
Total cash flows from investing $6.11 -$5.63 $22.94 $14.48
Financing activities
Dividends paid
Sale and purchase of stock $0.18 $0.03 $0.21 $0.03
Net borrowings
Total cash flows from financing $0.18 $0.03 $0.21 $0.03
Effect of exchange rate
Change in cash and equivalents -$3.9 -$20.01 $8.02 -$4.82
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$86.28 -$92.97 -$71.17 -$32.77
Operating activities
Depreciation $5.79 $5.9 $3.56 $1.61
Business acquisitions & disposals
Stock-based compensation $34.42 $33.67 $25.93 $7.35
Total cash flows from operations -$59.06 -$60.78 -$46.35 -$20.83
Investing activities
Capital expenditures -$7.31 -$10.1 -$6.92 -$4.53
Investments $45.21 -$112.62 -$163.96 -$30.02
Total cash flows from investing $37.9 -$122.72 -$170.88 -$34.56
Financing activities
Dividends paid
Sale and purchase of stock $0.45 $3.89 $105.23 $316.59
Net borrowings
Total cash flows from financing $0.45 $3.89 $116.63 $371.49
Effect of exchange rate
Change in cash and equivalents -$20.71 -$179.6 -$100.59 $316.1
Fundamentals
Market cap $122.17M
Enterprise value $117.40M
Shares outstanding 64.30M
Revenue $16.66M
EBITDA -$80.49M
EBIT -$86.28M
Net Income -$86.28M
Revenue Q/Q -3.63%
Revenue Y/Y 7.54%
P/E ratio -1.42
EV/Sales 7.05
EV/EBITDA -1.46
EV/EBIT -1.36
P/S ratio 7.33
P/B ratio 0.31
Book/Share 6.18
Cash/Share 0.51
EPS -$1.34
ROA -19.01%
ROE -20.87%
Debt/Equity 0.10
Net debt/EBITDA -0.08
Current ratio 25.00
Quick ratio 24.66